Innovative oncolytic virus drug development: First in Class and Best in Class
MORE +
Who we are
ABOUT VIROTECH
Guangzhou Virotech Pharmaceutical Co., Ltd. (hereinafter referred to as "Virotech") was registered and established in January 2015 at the Guangzhou International Business Incubator by Professor Yan Guangmei's original team from Sun Yat-sen University. It is committed to the development of innovative oncolytic virus drugs in First in Class and Best in Class, and strives to create oncolytic virus technology for root cancer. Since its establishment, Virotech has won multiple honors such as the Top 50 Most Innovative Chinese Biopharmaceutical Enterprises, Guangdong Province's Specialized and Innovative Small and Medium sized Enterprises, and Guangzhou's Future Unicorn Enterprise. It is one of the top biopharmaceutical enterprises in its segmented industry.
Virotech
Our services
Science and Product Pipeline
HONOR
China Patent Silver Award
Guangdong Province Specialized Special New Small and Medium Enterprises
Innovative smes in Guangdong Province
Guangzhou Entrepreneurship Leading Team
Leading talents of Guangzhou Development Zone
News Center
Latest developments
51% of clinical ADC drugs in China enter phase II and beyond trials
Adult transplant recipients with CMV infection or disease bring new treatment options
Global research and development of cancer vaccines to prevent and treat cancer
Focus on us
Contact Information
Monday to Friday 9:00~17:00
Rooms 801-808 and 901-908, Building H, No. 3 Jiu Quan Road, Huangpu District, Guangzhou City
Copyright©2024 Virotech Pharmaceutical Technology Co., Ltd.
